These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21166876)

  • 1. Continuous renal replacement therapy: cause and treatment of electrolyte complications.
    Fall P; Szerlip HM
    Semin Dial; 2010; 23(6):581-5. PubMed ID: 21166876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of continuous renal replacement therapy.
    Finkel KW; Podoll AS
    Semin Dial; 2009; 22(2):155-9. PubMed ID: 19426420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S; Pistolesi V; Cibelli L; Pierucci A
    G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrolyte disorders and substitution fluid in continuous renal replacement therapy.
    Locatelli F; Pontoriero G; Di Filippo S
    Kidney Int Suppl; 1998 May; 66():S151-5. PubMed ID: 9573593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of dialysate and replacement fluids and management of electrolyte and Acid-base disturbances.
    Kraus MA
    Semin Dial; 2009; 22(2):137-40. PubMed ID: 19426416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
    Oudemans-van Straaten HM
    Blood Purif; 2010; 29(2):191-6. PubMed ID: 20093826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit--the role of renal replacement therapy.
    Naka T; Bellomo R
    Crit Care; 2004 Apr; 8(2):108-14. PubMed ID: 15025771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guidelines for dialysis. Replacement therapy for acute renal failure in critically ill patients].
    Fuiano G; Di Filippo S; Memoli B; Cioffi M; Caglioti A; Mazza G;
    G Ital Nefrol; 2004; 21 Suppl 28():S1-10. PubMed ID: 15724231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysate and substitution fluids for patients treated by continuous forms of renal replacement therapy.
    Davenport A
    Contrib Nephrol; 2001; (132):313-22. PubMed ID: 11395899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Handling continuous renal replacement therapy-related adverse effects in intensive care unit patients: the dialytrauma concept.
    Maynar Moliner J; Honore PM; Sánchez-Izquierdo Riera JA; Herrera Gutiérrez M; Spapen HD
    Blood Purif; 2012; 34(2):177-85. PubMed ID: 23095418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Choice of renal replacement therapy].
    Favre H
    Schweiz Med Wochenschr; 1997 Jun; 127(25):1082-7. PubMed ID: 9312830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry.
    Sutherland SM; Zappitelli M; Alexander SR; Chua AN; Brophy PD; Bunchman TE; Hackbarth R; Somers MJ; Baum M; Symons JM; Flores FX; Benfield M; Askenazi D; Chand D; Fortenberry JD; Mahan JD; McBryde K; Blowey D; Goldstein SL
    Am J Kidney Dis; 2010 Feb; 55(2):316-25. PubMed ID: 20042260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid-base and electrolyte abnormalities during renal support for acute kidney injury: recognition and management.
    Claure-Del Granado R; Bouchard J
    Blood Purif; 2012; 34(2):186-93. PubMed ID: 23095419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkalemia during continuous renal replacement therapy and mortality in critically ill patients.
    Demirjian S; Teo BW; Paganini EP
    Crit Care Med; 2008 May; 36(5):1513-7. PubMed ID: 18434895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status.
    Morgera S; Schneider M; Slowinski T; Vargas-Hein O; Zuckermann-Becker H; Peters H; Kindgen-Milles D; Neumayer HH
    Crit Care Med; 2009 Jun; 37(6):2018-24. PubMed ID: 19384210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous renal replacement therapy for liver disease.
    Davenport A
    Hemodial Int; 2003 Oct; 7(4):348-52. PubMed ID: 19379387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino Acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
    Btaiche IF; Mohammad RA; Alaniz C; Mueller BA
    Pharmacotherapy; 2008 May; 28(5):600-13. PubMed ID: 18447659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.